Cite
HARVARD Citation
Kubo, S. et al. (n.d.). THU0203 Baricitinib Targets The Type I IFN/STAT-Medicated Activities of Human T Cells and Dendritic Cells. Annals of the rheumatic diseases. p. 260. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kubo, S. et al. (n.d.). THU0203 Baricitinib Targets The Type I IFN/STAT-Medicated Activities of Human T Cells and Dendritic Cells. Annals of the rheumatic diseases. p. 260. [Online].